A new CT-based analysis effectively predicts early recurrence in hepatocellular carcinoma, offering surgeons a powerful tool for patient stratification.

• The nested habitats score achieved area under the curve values of 0.832, 0.896, and 0.833 across three cohorts, indicating strong predictive power.
• It remains an independent predictor of recurrence-free survival alongside other known factors like alkaline phosphatase and tumor characteristics.

Use this score for enhanced postoperative risk stratification, ensuring better-targeted follow-up for high-risk patients.

Percutaneous transhepatic cholangioscopy (PTCS) is effective for treating postoperative benign bilioenteric strictures and biliary stones.

• Initial anastomotic patency rates are 58.1% at 1 year and 41.9% at 2 years.
• Cumulative patency rates drop to 34.8% after 7 years but treatment success is high at 90.6%.

These findings suggest PTCS should be a go-to for managing strictures, enhancing patient outcomes with minimal complications.

• Technical success rates were 100% for dilation and 94.5% for stone therapy.
• One case of manageable bleeding was reported.

Minimally invasive surgery (MIS) may preserve daily activities in patients over 80 with gastrointestinal and hepatobiliary cancers.

• Severe postoperative decline in daily living activities was 5.7% for MIS vs. 9.5% for open surgery, suggesting MIS is safer.
• 90-day readmission rates were lower for MIS at 16.6% compared to 22.3% for open surgery.

This approach is particularly beneficial for high-risk or frail patients.

• Intraoperative blood loss and length of stay were significantly better in the MIS group.